Lv31
250 积分 2023-09-12 加入
Annual review of PROTAC degraders as anticancer agents in 2022
2小时前
待确认
Chemistries of bifunctional PROTAC degraders
2小时前
已完结
Medicinal chemistry approaches to the discovery and development of p300/CBP inhibitors for cancer therapy
2小时前
已完结
Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore
11天前
已完结
Phenyl-benzyl-ureas with pyridazinone motif: Potent soluble epoxide hydrolase inhibitors with enhanced pharmacokinetics and efficacy in a paclitaxel-induced neuropathic pain model
11天前
已完结
Discovery of soluble epoxide hydrolase inhibitors from Inula britannica: Inhibition kinetics, molecular dynamics simulation, biochemical, and in vitro cell-based studies
11天前
已完结
Novel dual inhibitor targeting FAAH and sEH: Design, synthesis, and in-vitro evaluation of oxadiazole analogues
11天前
已完结
Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease
11天前
已完结
Repurposing of clinical-stage FLT3 inhibitor HYML-122 as a potent RIPK2 inhibitor for the treatment of inflammatory bowel disease
1个月前
已完结
Development of Thieno[3,2-d]pyrimidine Derivatives as Potent RIPK2 Inhibitors with Prominent In Vitro and In Vivo Anti-Inflammatory Efficacy
1个月前
已关闭
皖公网安备34019202002308
